PTEN and oligodendroglioma: Several previous studies that aimed to identify prognostic indicators of oligodendroglioma proposed the use of CDKN2A/B, PTEN, NOTCH1, and other biomarkers as classification criteria to reclassify oligodendroglioma, but there is no consistent conclusion (22–25).